{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:11:12Z","timestamp":1792480272629,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2025-02213534"],"award-info":[{"award-number":["RS-2025-02213534"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00401422"],"award-info":[{"award-number":["RS-2024-00401422"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00209053"],"award-info":[{"award-number":["RS-2023-00209053"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002573","name":"Yonsei University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019211","name":"Institute of Engineering Research, Seoul National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019211","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijbiomac.2025.149080","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:10:12Z","timestamp":1763629812000},"page":"149080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P2","title":["Mimotopes of calcitonin gene-related peptide (CGRP) screened from Fv-antibody library: antagonists to CGRP receptor"],"prefix":"10.1016","volume":"334","author":[{"given":"Jeong Soo","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Eun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Kyung","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Chul","family":"Pyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.149080_bb0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1526-4610.2006.00483.x","article-title":"Calcitonin gene-related peptide (CGRP) and migraine","volume":"46","author":"Durham","year":"2006","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149080_bb0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies\u2014successful translation from bench to clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149080_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/WCO.0000000000000440","article-title":"Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine","volume":"30","author":"Ram\u00f3n","year":"2017","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149080_bb0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijbiomac.2025.149080_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.720561","article-title":"Exploring ligand binding to calcitonin gene-related peptide receptors","volume":"8","author":"Deganutti","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"7724","key":"10.1016\/j.ijbiomac.2025.149080_bb0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41586-018-0535-y","article-title":"Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor","volume":"561","author":"Liang","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149080_bb0035","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.molcel.2015.04.018","article-title":"Structural basis for receptor activity-modifying protein-dependent selective peptide recognition by a G protein-coupled receptor","volume":"58","author":"Booe","year":"2015","journal-title":"Mol. Cell"},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.149080_bb0040","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1212\/WNL.0b013e3182a6cb72","article-title":"Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine","volume":"81","author":"Cernuda-Moroll\u00f3n","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.149080_bb0045","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/0333102410368444","article-title":"Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura","volume":"30","author":"Hansen","year":"2010","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149080_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/14728222.2020.1724285","article-title":"Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting","volume":"24","author":"Wattiez","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149080_bb0055","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/0333102417736900","article-title":"Recognizing the role of CGRP and CGRP receptors in migraine and its treatment","volume":"39","author":"Edvinsson","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ijbiomac.2025.149080_bb0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/bs.pbr.2020.06.019","article-title":"Calcitonin gene-related peptide (CGRP)-targeted therapies as preventive and acute treatments for migraine\u2014the monoclonal antibodies and gepants","volume":"255","author":"Chiang","year":"2020","journal-title":"Prog. Brain Res."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.149080_bb0065","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1177\/03331024211024161","article-title":"CGRP measurements in human plasma\u2013a methodological study","volume":"41","author":"Messlinger","year":"2021","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149080_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.17340\/jkna.2020.2.2","article-title":"Calcitonin gene-related peptide targeting therapies for migraine: a new era for migraine treatment","volume":"38","author":"Park","year":"2020","journal-title":"J. Korean Neurol. Assoc."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.149080_bb0075","first-page":"566","article-title":"Drug profile: olcegepant, a non-peptide CGRP1 antagonist for migraine treatment","volume":"10","author":"Recober","year":"2007","journal-title":"IDrugs"},{"key":"10.1016\/j.ijbiomac.2025.149080_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.116980","article-title":"One-step ultra-rapid immunoassay of calcitonin gene-related peptide for migraine diagnosis","volume":"270","author":"Sung","year":"2025","journal-title":"Biosens. Bioelectron."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149080_bb0085","first-page":"598","article-title":"Clinical evaluation of zavegepant for the acute treatment of migraine","volume":"31","author":"Fan","year":"2025","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149080_bb0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40263-023-00988-8","article-title":"Rimegepant: a review in the acute treatment and preventive treatment of migraine","volume":"37","author":"Blair","year":"2023","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149080_bb0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40259-022-00530-0","article-title":"Calcitonin gene-related peptide (CGRP)-targeted monoclonal antibodies and antagonists in migraine: current evidence and rationale","volume":"36","author":"Cohen","year":"2022","journal-title":"BioDrugs"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149080_bb0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40120-024-00586-w","article-title":"Safety and tolerability of combining CGRP monoclonal antibodies with gepants in patients with migraine: a retrospective study","volume":"13","author":"Alsaadi","year":"2024","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.149080_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1387044","article-title":"Safety considerations in the treatment with anti-CGRP (R) monoclonal antibodies in patients with migraine","volume":"15","author":"Van Der Arend","year":"2024","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149080_bb0110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/bjp.2008.346","article-title":"CGRP blockers in migraine therapy: where do they act?","volume":"155","author":"Edvinsson","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149080_bb0115","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1021\/acs.bioconjchem.2c00107","article-title":"Antibody-mediated screening of peptide inhibitors for monoamine oxidase-B (MAO-B) from an autodisplayed FV library","volume":"33","author":"Sung","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijbiomac.2025.149080_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.113976","article-title":"One-step immunoassay for food allergens based on screened mimotopes from autodisplayed FV-antibody library","volume":"202","author":"Sung","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.ijbiomac.2025.149080_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140770","article-title":"Screening of deoxyribonuclease I inhibitors from autodisplayed Fv-antibody library","volume":"304","author":"Bae","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.149080_bb0130","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1021\/acsptsci.3c00232","article-title":"Screening of pancreatic ribonuclease A inhibitors from an autodisplayed Fv-antibody library","volume":"6","author":"Sung","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149080_bb0135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acsptsci.3c00204","article-title":"Monoamine oxidase-A (MAO-A) Inhibitors screened from the autodisplayed Fv-antibody library","volume":"7","author":"Sung","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.149080_bb0140","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1039\/D4TB02793K","article-title":"Penicillin-like mimotopes from autodisplayed Fv-antibody library inhibiting \u03b2-lactamase activity","volume":"13","author":"Bae","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ijbiomac.2025.149080_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130854","article-title":"Monocarboxylate transporter-1 (MCT-1) inhibitors screened from autodisplayed FV-antibody library","volume":"265","author":"Sung","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149080_bb0150","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1021\/acs.bioconjchem.4c00256","article-title":"Epidermal growth factor receptor (EGFR) inhibitors screened from autodisplayed Fv-antibody library","volume":"35","author":"Sung","year":"2024","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149080_bb0155","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/MMBR.00011-07","article-title":"The autodisplay story, from discovery to biotechnical and biomedical applications","volume":"71","author":"Jose","year":"2007","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149080_bb0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s13206-024-00139-1","article-title":"Surface plasmon resonance (SPR) biosensor for the detection of SARS-CoV-2 using autodisplyaed FV-antibodies on outer membrane of E. coli","volume":"18","author":"Bong","year":"2024","journal-title":"Biochip J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149080_bb0165","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s13206-024-00151-5","article-title":"One-step immunoassay for the detection of SARS-CoV-2 nucleocapsid protein using screened Fv-antibodies","volume":"18","author":"Jung","year":"2024","journal-title":"Biochip J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149080_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13206-024-00185-9","article-title":"One-step immunoassay for the detection of influenza virus based on screened nucleoprotein (NP)-like mimotopes from Fv-antibody library","volume":"19","author":"Kim","year":"2025","journal-title":"Biochip J."},{"key":"10.1016\/j.ijbiomac.2025.149080_bb0175","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.mie.2014.11.003","article-title":"Purification of His-tagged proteins","author":"Spriestersbach","year":"2015"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149080_bb0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/adt.2006.055","article-title":"A bioluminescent-based, HTS-compatible assay to monitor G-protein-coupled receptor modulation of cellular cyclic AMP","volume":"5","author":"Kumar","year":"2007","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ijbiomac.2025.149080_bb0185","series-title":"A Pharmacology Primer: Techniques for More Effective and Strategic Drug Discovery","author":"Kenakin","year":"2018"},{"issue":"39","key":"10.1016\/j.ijbiomac.2025.149080_bb0190","doi-asserted-by":"crossref","first-page":"25381","DOI":"10.1021\/acsomega.0c03759","article-title":"IC50 evaluation of platinum nanocatalysts for cancer treatment in fibroblast, HeLa, and DU-145 cell lines","volume":"5","author":"Gonz\u00e1lez-Larraza","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2025.149080_bb0195","doi-asserted-by":"crossref","first-page":"17931","DOI":"10.1021\/acs.jmedchem.4c02052","article-title":"Dose\u2013response curves and the determination of IC50 and EC50 values","author":"Srinivasan","year":"2024","journal-title":"J. Med. Chem."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2025.149080_bb0200","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkw329","article-title":"PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex","volume":"44","author":"Lamiable","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.149080_bb0205","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2. 0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149080_bb0210","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149080_bb0215","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.joca.2014.01.009","article-title":"Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain","volume":"22","author":"Benschop","year":"2014","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149080_bb0220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(00)00934-1","article-title":"Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries","volume":"415","author":"Edvinsson","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.149080_bb0225","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1021\/acs.bioconjchem.1c00376","article-title":"Fluorescein and rhodamine B-binding domains from autodisplayed Fv-antibody library","volume":"32","author":"Jung","year":"2021","journal-title":"Bioconjug. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149080_bb0230","article-title":"Using BLOSUM in sequence alignments","volume":"2008","author":"Mount","year":"2008","journal-title":"Cold Spring Harb Protoc"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149080_bb0235","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/sj.bjp.0706750","article-title":"Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture","volume":"148","author":"Takhshid","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.149080_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10194-019-0992-1","article-title":"Effects of monoclonal antagonist antibodies on calcitonin gene-related peptide receptor function and trafficking","volume":"20","author":"Manoukian","year":"2019","journal-title":"J. Headache Pain"},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.149080_bb0245","doi-asserted-by":"crossref","first-page":"10644","DOI":"10.1021\/jm3013147","volume":"55","author":"Luo","year":"2012","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149080_bb0250","doi-asserted-by":"crossref","DOI":"10.1177\/03331024231226186","article-title":"Pharmacologic characterization of atogepant: a potent and selective calcitonin gene\u2013related peptide receptor antagonist","volume":"44","author":"Moore","year":"2024","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149080_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-84547-1","article-title":"Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment","volume":"15","author":"Kristensen","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149080_bb0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1139\/y82-036","article-title":"The Schild regression in the process of receptor classification","volume":"60","author":"Kenakin","year":"1982","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149080_bb0265","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.bjp.0706997","article-title":"Taking the time to study competitive antagonism","volume":"150","author":"Wyllie","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.149080_bb0270","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3390\/ph16081075","article-title":"Blocking the CGRP receptor: differences across human vascular beds","volume":"16","author":"de Vries","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149080_bb0275","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bph.16218","article-title":"Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene-related peptide responsive receptors","volume":"181","author":"Garelja","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149080_bb0280","doi-asserted-by":"crossref","first-page":"H960","DOI":"10.1152\/ajpheart.00059.2005","article-title":"Ca2+ signaling in human fetoplacental vasculature: effect of CGRP on umbilical vein smooth muscle cytosolic Ca2+ concentration","volume":"289","author":"Dong","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijbiomac.2025.149080_bb0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1006962221332","article-title":"Calcitonin gene-related peptide receptor independently stimulates 3\u2032, 5\u2032-cyclic adenosine monophosphate and Ca2+ signaling pathways","volume":"197","author":"Aiyar","year":"1999","journal-title":"Mol. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.149080_bb0290","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1523\/JNEUROSCI.19-08-02945.1999","article-title":"Calcitonin gene-related peptide rapidly downregulates nicotinic receptor function and slowly raises intracellular Ca2+ in rat chromaffin cells in vitro","volume":"19","author":"Giniatullin","year":"1999","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149080_bb0295","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1054\/ceca.1999.0095","article-title":"Chemical and physiological characterization of fluo-4 Ca2+-indicator dyes","volume":"27","author":"Gee","year":"2000","journal-title":"Cell Calcium"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149080_bb0300","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1476-5381.2010.00863.x","article-title":"Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays","volume":"161","author":"Charlton","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149080_bb0305","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.str.2010.05.014","article-title":"Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism","volume":"18","author":"ter Haar","year":"2010","journal-title":"Structure"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149080_bb0310","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.celrep.2020.01.029","article-title":"Molecular insight into recognition of the CGRPR complex by migraine prevention therapy Aimovig (Erenumab)","volume":"30","author":"Garces","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149080_bb0315","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s10194-023-01644-8","article-title":"Mode and site of action of therapies targeting CGRP signaling","volume":"24","author":"Labastida-Ram\u00edrez","year":"2023","journal-title":"J. Headache Pain"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149080_bb0320","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2009.11.076","article-title":"Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74","volume":"391","author":"Miller","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6538","key":"10.1016\/j.ijbiomac.2025.149080_bb0325","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf7258","article-title":"Structure and dynamics of the CGRP receptor in apo and peptide-bound forms","volume":"372","author":"Josephs","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149080_bb0330","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s10194-022-01425-9","article-title":"Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor","volume":"23","author":"Hage La Cour","year":"2022","journal-title":"J. Headache Pain"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149080_bb0335","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/acsptsci.8b00017","article-title":"Dominant negative G proteins enhance formation and purification of agonist-GPCR-G protein complexes for structure determination","volume":"1","author":"Liang","year":"2018","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149080_bb0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bph.14075","article-title":"Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR Review 25","volume":"175","author":"Hay","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"27","key":"10.1016\/j.ijbiomac.2025.149080_bb0345","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202201481","article-title":"A series of novel bioactive cyclic peptides: synthesis by head-to-tail cyclization approach, antimicrobial activity and molecular docking studies","volume":"7","author":"Tivari","year":"2022","journal-title":"ChemistrySelect"},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.149080_bb0350","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.1039\/C6CP01555G","article-title":"Comprehensive evaluation of ten docking programs on a diverse set of protein\u2013ligand complexes: the prediction accuracy of sampling power and scoring power","volume":"18","author":"Wang","year":"2016","journal-title":"Phys. Chem. Chem. Phys."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025096370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025096370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:49:25Z","timestamp":1781167765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025096370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":70,"alternative-id":["S0141813025096370"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149080","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mimotopes of calcitonin gene-related peptide (CGRP) screened from Fv-antibody library: antagonists to CGRP receptor","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149080"}}